ARMISTICE CAPITAL, LLC: 13F holdings
CIK 16010862026Q2
| Positions | 325 |
|---|
| Reported value | $8.2bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 325 (+72 vs prior quarter) |
|---|
| Reported value | $8.2bn (+45.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| MDGL MADRIGAL PHARMACEUTICALS INC | 288,000 | $154.6m | 1.9% |
| SUPN SUPERNUS PHARMACEUTICALS | 2,646,201 | $123.1m | 1.5% |
| CYTK CYTOKINETICS INC | 1,201,342 | $102.3m | 1.3% |
| INCY INCYTE CORP | 900,005 | $102.0m | 1.2% |
| NBIX NEUROCRINE BIOSCIENCES INC | 535,838 | $90.3m | 1.1% |
| TVTX TRAVERE THERAPEUTICS INC | 1,572,539 | $89.3m | 1.1% |
| AGIO AGIOS PHARMACEUTICALS INC | 2,400,000 | $89.1m | 1.1% |
| PTCT PTC THERAPEUTICS INC | 1,071,395 | $87.4m | 1.1% |
| UNH UNITEDHEALTH GROUP INC | 183,000 | $76.1m | 0.9% |
| FRPT FRESHPET INC | 1,260,702 | $74.5m | 0.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1601086")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples